A Research On Financial Early Warning For Sinobioway Medicine Based On Entropy Method And Efficacy Coefficient Method

With the continuous spread of COVID-19 in various countries,the pharmaceutical industry has become the focus of attention all over the world,and our country is paying more and more attention to the development of the pharmaceutical industry.The pharmaceutical industry has the characteristics of high R&D investment and long R&D cycle.Under the complex and severe international environment and the pressure of economic downturn,the financial and operational risks it faces can not be underestimated,and a little carelessness may evolve into a financial crisis.Therefore,it is of great significance for the development of the pharmaceutical industry to establish a financial early warning mechanism within the enterprise and correctly identify and deal with financial risks.Through the case study method,this thesis selects enterprises with certain financial risks in the pharmaceutical industry,and finally selects SINOBIOWAY Medicine as the case company.This thesis first introduces the reasons for choosing the pharmaceutical industry as the starting point of financial early warning research,then summarizes the literature research results of financial early warning at home and abroad,and puts forward the research idea of why to choose the efficacy coefficient method as the financial early warning model.Secondly,through the introduction of SINOBIOWAY Medicine,internal and external risk analysis and risk analysis of the pharmaceutical industry,this thesis puts forward the necessity of establishing the financial early warning model of the pharmaceutical industry.Then,referring to the relevant enterprise performance evaluation standards issued by SASAC,firstly,the enterprise financial indicators that meet the requirements are screened out,and the basic standard value and the evaluation interval of financial early warning are set,and then the entropy method is used to calculate the weight of each index.Finally,the efficacy coefficient method is used to count the score value and comprehensive score of the single index,and the alarm degree of the financial indicators of SINOBIOWAY Medicine in 2016-2020 and all dimensions is determined according to the divided early warning interval.It can be seen from the research of this thesis that the financial situation of SINOBIOWAY Medicine is not optimistic.The financial risk alarm degree of the enterprise has been in the state of heavy alarm since 2016,and has deteriorated year by year.It has reached the state of huge alarm from 2018 to 2020,and its financial risk is mainly concentrated in operation capacity and development capacity,so it is urgent to take measures to deal with the risk.This shows that the financial early warning model based on the efficacy coefficient method has a certain practical warning significance.It can timely find the deterioration of the financial situation of pharmaceutical enterprises,find out the weak links in the operation of enterprises,and take preventive measures to help enterprises develop better and healthy in the long term.